HBIO
HARVARD BIOSCIENCE INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$8.09
+0.00%Forward multiples
Based on analyst estimates
- P/E forward
- 12.45x
- P/E 2026E
- —
- P/E 2027E
- 12.56x
- P/E 2028E
- —
- P/S forward
- 0.40x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.96x
- Price / sales
- 0.42x
- Price / cash flow
- 56.75x
Enterprise value
- Enterprise value
- $74.5M
- EV / sales
- 0.85x
- EV / EBITDA
- -42.52x
- EV / EBIT
- 72.57x
- Market cap
- $36.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026